Canadian Cancer Society - Innovation to Impact Grant

Innovation to Impact Grants

This program is designed to support the logical next steps of a positive, innovative, 'high risk/high reward' research grant, with the goal of working towards or achieving a significant impact on cancer.

Originally designed to continue the CCS funding pipeline between successful Innovation and Impact Grants, with the merger between the CCS and the Canadian Breast Cancer Foundation (CBCF), eligibility for Innovation to Impact Grants has been expanded for this competition only. Applicants are cautioned to carefully review the full description for details on the eligibility criteria for this funding opportunity.


Scientific focus of the program and eligibility

Innovation to Impact Grants (i2I) are intended to support the further development of significant findings based on the goals originally explored through a funded CCS Innovation Grant or an eligible CBCF grant. Note: Only investigators with a funded Innovation Grant OR CBCF grant with a project end date between January 1, 2015 and July 31, 2018 are eligible for this program.


Applicants are required to articulate significant achievements from the original Innovation Grant or CBCF Grant (i.e., significant new knowledge, publications, intellectual property, technology development, or relevant endpoints) and clearly describe and justify the progression to the new research proposed. Applicants must also describe the potential for impact of the proposed project on cancer. Any applications that are not appropriate, as determined through a review of the abstract registration, will not be eligible to proceed to the full application stage.


Investigators looking to explore unexpected outcomes or ideas not originally proposed in a funded Innovation Grant or CBCF grant are encouraged to apply for a new Innovation Grant as the Innovation to Impact Grant program is designed to build upon successful outcomes from the objectives of the original Innovation/CBCF grant.

Please see the eligibility and requirements section prior to creating an application.


Deadline dates

Abstract registration due date: December 15, 2017
Relevance review results: early February, 2018
Full application due date: March 29, 2018
Results announcement: mid-late July
Anticipated start date: August 1, 2018

Application guides can be found on the EGrAMS documentation for applicants page. See FAQs.

Abstract registration must be completed in order to submit a full application. An eligibility review will be conducted and only successful applicants will be invited to submit a Full Application.

Agency Name: 
Canadian Cancer Society
Contact Name: 
Penny D'Agnone
Grant Amount: 
Grant budgets may be up to $150,000 per year with a maximum of 3 years of funding. Grants will be non-renewable. Funding will be provided to support the direct costs of research, including supplies, salaries, and equipment associated with the proposed work. Equipment requests should not exceed $50,000 of the requested budget however an increase in this portion of the budget will be considered as an exceptional case if the i2I application involves the development of a technology or a platform that requires specific equipment to do so. Indirect costs are not eligible. It is expected that up to 11 grants will be awarded in this competition.
Grant Location: 
External Deadline: 
Friday, December 15, 2017
Grant Type: 
Grant Area: 
Grant Eligibility: